Stay updated on LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page now displays the study record for the LMB-100 followed by pembrolizumab mesothelioma trial, including its terminated status, study design, participant criteria, and results. It also provides study dates, investigator and sponsor details, and study documents.
    Difference
    60%
    Check dated 2026-11-08T14:15:45.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.2 to v3.8.0. The study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T15:37:58.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.
    Difference
    1%
    Check dated 2026-10-25T14:36:09.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T14:59:21.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the ClinicalTrials.gov error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:15:28.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the full study record content with a minimal error page; core elements such as study details and related documents are no longer accessible.
    Difference
    21%
    Check dated 2026-09-20T10:36:43.000Z thumbnail image

Stay in the know with updates to LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LMB-100 and Pembrolizumab in Mesothelioma Clinical Trial page.